Insider Transactions in Q2 2022 at Personalis, Inc. (PSNL)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,440
-1.46%
|
$10,320
$3.29 P/Share
|
|
Jun 17
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,565
-1.06%
|
$4,695
$3.29 P/Share
|
|
Jun 15
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
6,818
-2.82%
|
$20,454
$3.24 P/Share
|
|
Jun 15
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
6,818
-4.4%
|
$20,454
$3.24 P/Share
|
|
Jun 15
2022
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,832
-2.42%
|
$5,496
$3.24 P/Share
|
|
Jun 02
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
421
-0.27%
|
$1,263
$3.59 P/Share
|
|
Jun 02
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
4,187
-1.7%
|
$12,561
$3.59 P/Share
|
|
May 17
2022
|
Ken Ludlum Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+19.84%
|
-
|
|
May 17
2022
|
Alan Colowick Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+44.36%
|
-
|
|
May 17
2022
|
A Blaine Bowman |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+44.36%
|
-
|
|
May 17
2022
|
Karin Eastham |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+44.36%
|
-
|
|
May 17
2022
|
Woodrow A Myers Jr |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+40.06%
|
-
|
|
May 17
2022
|
Olivia Kyusuk Bloom |
BUY
Grant, award, or other acquisition
|
Direct |
10,770
+33.88%
|
-
|
|
May 16
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,286
-0.82%
|
$5,144
$4.86 P/Share
|
|
May 16
2022
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
664
-0.87%
|
$2,656
$4.86 P/Share
|
|
May 16
2022
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
2,408
-0.63%
|
$9,632
$4.86 P/Share
|
|
May 16
2022
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
1,286
-0.52%
|
$5,144
$4.86 P/Share
|
|
May 02
2022
|
Stephen Michael Moore SVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,733
-6.98%
|
$28,665
$5.53 P/Share
|
|
Apr 29
2022
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Grant, award, or other acquisition
|
Direct |
1,558
+0.98%
|
$6,232
$4.76 P/Share
|
|
Apr 20
2022
|
John Stephen West President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,061
+10.48%
|
$45,061
$1.84 P/Share
|
|
Apr 13
2022
|
John Stephen West President and CEO |
SELL
Open market or private sale
|
Direct |
64,430
-15.94%
|
-
|
|
Apr 13
2022
|
John Stephen West President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
64,430
+13.75%
|
$64,430
$1.84 P/Share
|